Antibodies

Latest articles from this sub-category

News releases from this sub-category

Showing 176-196 of 196 articles

first
1
2
3
4
5
6
7

Further TroVax phase ii trial in colorectal cancer

Oxford BioMedica reports that Cancer Research UK has agreed to conduct and sponsor an open label Phase II trial with TroVax, in colorectal cancer patients who have liver metastases.

News from Oxford BioMedica, Aug 29, 2003

Receptors for cellular localisation and staining

Range of antibodies suitable for either immunohistochemistry or immunocytochemistry procedures, making them ideal for cellular localisation or tissue staining

News from Cambridge BioScience, Aug 21, 2003

Further patent for LentiViral gene therapy

Oxford BioMedica has received allowance from the US Patent Office for a further patent covering its proprietary LentiVector technology

News from Oxford BioMedica, Aug 14, 2003

Improved yields of monoclonal antibodies

Laboratories producing monoclonal antibodies for numerous biological applications using tissue culture flasks or roller bottles are set to benefit from this development

News from Integra Biosciences, Jul 10, 2003

Brochure available

Positive results from MetXia breast cancer trial

Oxford BioMedica announced encouraging results from its ongoing Phase I/II trial with MetXia in breast cancer patients

News from Oxford BioMedica, Jul 4, 2003

Manufacturing process for Parkinson's drug

First discussion of the novel production approach used for ProSavin, a LentiVector-based product, to be made at Bio 2003 this week in Washington DC.

News from Oxford BioMedica, Jun 25, 2003

TroVax passes key regulatory hurdle in the USA

Oxford BioMedica's TroVax Receives Clearance from the United States Recombinant DNA Advisory Committee to Enter a Clinical Trial for Renal Cancer

News from Oxford BioMedica, May 21, 2003

An alternative to antibody production in mice

Hollow fibre in-vitro cell cultivation system offers production of monoclonal antibodies and expression of cell products over a period of months, avoiding the need for laboratory animals

News from Integra Biosciences, May 20, 2003

Brochure available

Preclinical results from the RetinoStat

Oxford BioMedica and Institute of Ophthalmology describe key features of vision-loss product RetinoStat at the 2003 Annual Meeting of the Association for Research in Vision and Ophthalmology (Arvo)

News from Oxford BioMedica, May 7, 2003

European therapeutic monoclonal antibodies market

High specificity boosts prospects of Mabs, but price issues keep market on the back foot, says consultant's report

News from Frost and Sullivan, Apr 7, 2003

Genetic vector technology licenced

May prove key to development of avian transgenic technology as a novel platform for the efficient, cost-effective manufacturing of protein drugs

News from Oxford BioMedica, Mar 21, 2003

Colorectal cancer drug gets Phase II go-ahead

Product is based on a gene that encodes a protein, known as 5T4, which exists only on the surface of tumour cells and not on normal cells

News from Oxford BioMedica, Mar 13, 2003

Wyeth exercises option on anti-tumour antibody

Antibody is directed against a novel proprietary tumour-associated antigen that is expressed on a wide range of solid tumours

News from Oxford BioMedica, Mar 11, 2003

Ethical approval for TroVax trial

Oxford BioMedica has received ethical approval from the UK Gene Therapy Advisory Committee for TroVax to enter a Phase II clinical trial in patients receiving chemotherapy for colorectal cancer

News from Oxford BioMedica, Mar 4, 2003

Affinity purified anti-ATM protein kinase

A series of phospho specific antibodies to ATM protein kinase, the gene mutated in the hereditary disease ataxia-telangiectasia

News from Rockland Immunochemicals, Feb 11, 2003

New antibodies for transcription research

For use in the detection and identification of nuclear factor kappa B, they are ideal for use in western blotting, immunoprecipitation and immunohistochemistry

News from Cambridge BioScience, Jan 28, 2003

New labelling kit for polyclonal Rabbit antibodies

Molecular Probes' Zenon technology has revolutionised the fluorescent labelling of monoclonal Mouse antibodies, and it's now offered for use with polyclonal Rabbit antibodies

News from Cambridge BioScience, Jan 15, 2003

Antibodies optimised for automated immunostainers

Cambridge BioScience is launching a new range of Zymed antibodies which are optimised for use with the Ventana, DAKO and BioGenex automated staining platforms.

News from Cambridge BioScience, Dec 24, 2002

Polyclonal production facility

Harlan Sera-Lab has completed its new polyclonal unit, with capacity for over 900 rabbits

News from Harlan Sera-lab, Jul 16, 2001

Guinea-pig polyclonal antibody to nicastrin

Immunohistochemical analysis reveals that nicastrin is localised to neurons known to be affected by Alzheimer's; Chemicon announces its new guinea-pig polyclonal antibody

News from Chemicon International, Jul 11, 2001

Monoclonal antibody production

Monoclonal antibody production Immunochemicals has just completed a 15,000-sqft laboratory expansion to support its custom monoclonal antibody development programme

News from Rockland Immunochemicals, Jul 10, 2001

Showing 176-196 of 196 articles

first
1
2
3
4
5
6
7

Not what you're looking for? Search the site.

Everest appoints sales and marketing head

Everest Biotech has appointed Tim Bernard, formerly managing director of antibody company AbD Serotec, as head of Sales and Marketing.

Request your free weekly copy of the Laboratorytalk email newsletter ...

Laboratorytalk